Market Cap 341.08M
Revenue (ttm) 70.01M
Net Income (ttm) 9.95M
EPS (ttm) N/A
PE Ratio 24.07
Forward PE 17.48
Profit Margin 14.21%
Debt to Equity Ratio 0.00
Volume 6,146,400
Avg Vol 450,356
Day's Range N/A - N/A
Shares Out 20.11M
Stochastic %K 33%
Beta 0.83
Analysts Strong Sell
Price Target $32.25

Company Profile

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides prod...

Industry: Health Information Services
Sector: Healthcare
Phone: 661 723 7723
Address:
42505 Tenth Street West, Lancaster, United States
mTOR
mTOR Jul. 15 at 11:45 PM
$SLP dang what the heck happened to this stock
0 · Reply
Marklark
Marklark Jul. 15 at 7:31 PM
$SLP without any reason -25% shame
1 · Reply
BigMacdx
BigMacdx Jul. 15 at 6:18 PM
$SLP something is brewing
1 · Reply
Chomo
Chomo Jul. 15 at 6:11 PM
$SLP capitulation? the worst day in year now on the highest volume in that period too.
0 · Reply
Jamesiam
Jamesiam Jul. 15 at 5:30 PM
$SLP $9 is the bottom
1 · Reply
LucienW
LucienW Jul. 15 at 5:26 PM
$SLP quadrupled my holdings today. Will add more if it keeps dropping
0 · Reply
Bazzzigar
Bazzzigar Jul. 15 at 2:52 PM
0 · Reply
syes
syes Jul. 15 at 2:46 PM
$SLP I believe this is an overreaction, company is still profitable
0 · Reply
Drugtrade
Drugtrade Jul. 15 at 2:36 PM
$SLP p/e back on earth, very profitable should recover long $20+
0 · Reply
Marklark
Marklark Jul. 15 at 2:33 PM
$SLP what a shame
0 · Reply
Latest News on SLP
Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Jul 15, 2025, 1:56 PM EDT - 7 hours ago

Simulations Plus Sees Weaker Demand Persist, Outlook Softens


Simulations Plus: Further Downside Is Likely (Rating Downgrade)

Jun 13, 2025, 8:45 AM EDT - 4 weeks ago

Simulations Plus: Further Downside Is Likely (Rating Downgrade)


Simulations Plus Releases ADMET Predictor® 13

Jun 5, 2025, 7:50 AM EDT - 5 weeks ago

Simulations Plus Releases ADMET Predictor® 13


Simulations Plus Releases DILIsym® 11

May 15, 2025, 7:50 AM EDT - 2 months ago

Simulations Plus Releases DILIsym® 11


Simulations Plus: Benefiting From FDA Modernization And AI

Apr 16, 2025, 8:30 AM EDT - 3 months ago

Simulations Plus: Benefiting From FDA Modernization And AI


Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript

Apr 3, 2025, 8:44 PM EDT - 3 months ago

Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript


Top 3 Health Care Stocks That Are Set To Fly This Month

Mar 26, 2025, 7:06 AM EDT - 3 months ago

Top 3 Health Care Stocks That Are Set To Fly This Month

ARVN IOVA


Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript

Jan 7, 2025, 9:08 PM EST - 6 months ago

Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript


Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript

Oct 23, 2024, 11:55 PM EDT - 9 months ago

Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript


Simulations Plus Releases DILIsym® X

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Simulations Plus Releases DILIsym® X


Simulations Plus Releases ADMET Predictor® Version 12

Jul 30, 2024, 8:30 AM EDT - 1 year ago

Simulations Plus Releases ADMET Predictor® Version 12


QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

Jun 12, 2024, 8:58 AM EDT - 1 year ago

QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus


mTOR
mTOR Jul. 15 at 11:45 PM
$SLP dang what the heck happened to this stock
0 · Reply
Marklark
Marklark Jul. 15 at 7:31 PM
$SLP without any reason -25% shame
1 · Reply
BigMacdx
BigMacdx Jul. 15 at 6:18 PM
$SLP something is brewing
1 · Reply
Chomo
Chomo Jul. 15 at 6:11 PM
$SLP capitulation? the worst day in year now on the highest volume in that period too.
0 · Reply
Jamesiam
Jamesiam Jul. 15 at 5:30 PM
$SLP $9 is the bottom
1 · Reply
LucienW
LucienW Jul. 15 at 5:26 PM
$SLP quadrupled my holdings today. Will add more if it keeps dropping
0 · Reply
Bazzzigar
Bazzzigar Jul. 15 at 2:52 PM
0 · Reply
syes
syes Jul. 15 at 2:46 PM
$SLP I believe this is an overreaction, company is still profitable
0 · Reply
Drugtrade
Drugtrade Jul. 15 at 2:36 PM
$SLP p/e back on earth, very profitable should recover long $20+
0 · Reply
Marklark
Marklark Jul. 15 at 2:33 PM
$SLP what a shame
0 · Reply
Jamesiam
Jamesiam Jul. 15 at 2:08 PM
$SLP I don’t think their services are no longer needed since AI can do everything they do
0 · Reply
Chomo
Chomo Jul. 15 at 1:58 PM
0 · Reply
Phonic
Phonic Jul. 15 at 1:54 PM
$SLP sup here?
0 · Reply
yaboy90
yaboy90 Jul. 15 at 1:53 PM
$SLP jesus 😳
0 · Reply
LucienW
LucienW Jul. 15 at 1:42 PM
$SLP loading time
0 · Reply
Bazzzigar
Bazzzigar Jul. 15 at 1:35 PM
$SLP in
1 · Reply
Stephan1988
Stephan1988 Jul. 15 at 1:31 PM
$SLP Damn, 10% up after ER, and now almost 20% down at 14 😅😅
0 · Reply
ZacksResearch
ZacksResearch Jul. 15 at 1:25 PM
$SLP jumps on a 67% earnings beat — but is it all smooth sailing? Q3 strength came from Pro-ficiency, yet the lowered 2025 outlook signals pressure in biosimulation and services. The full bull/bear case on SLP 👉 https://www.zacks.com/stock/news/2582335/slps-q3-earnings-top-sales-up-yy-stock-gains-despite-lowered-view?cid=sm-stocktwits-2-2582335-teaser-1770&ADID=SYND_STOCKTWITS_TWEET_2_2582335_TEASER_1770
0 · Reply
GetVector
GetVector Jul. 15 at 12:52 PM
Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $ANGO, $SLP.
0 · Reply
Stephan1988
Stephan1988 Jul. 15 at 12:43 PM
$SLP down 15% this PM after a spike of +10% during AH...
0 · Reply
ZacksResearch
ZacksResearch Jul. 15 at 12:21 PM
$SLP reports a 66.7% EPS growth but faces major headwinds! ⚠️ 🚀 EPS of 45 cents beats Zacks Consensus Estimate by 73% 📉 Organic revenue drops 4% amid declining software sales 🔄 Strategic reorg aims to boost efficiency & growth Full story here 👉 https://www.zacks.com/stock/news/2582335/slps-q3-earnings-top-sales-up-yy-stock-gains-despite-lowered-view?cid=sm-stocktwits-2-2582335-body-1714&ADID=SYND_STOCKTWITS_TWEET_2_2582335_BODY_1714
0 · Reply
JarvisFlow
JarvisFlow Jul. 15 at 12:00 PM
Stephens & Co. updates rating for Simulations Plus ( $SLP ) to Overweight, target set at 28 → 20.
0 · Reply